Bone metabolism disorders caused by sodium valproate therapy in children with epilepsy and the prevention of the disorders by supplementation of calcium and vitamin D
LIANG Ying-Wu1, FENG Qing1, ZHANG Yan-Li1, et al
Department of Pediatric Neurology, Jining First People’s Hospital, Jining Medical College, Jining, Shandong 272011, China
LIANG Ying-Wu,FENG Qing,ZHANG Yan-Li et al. Bone metabolism disorders caused by sodium valproate therapy in children with epilepsy and the prevention of the disorders by supplementation of calcium and vitamin D[J]. CJCP, 2017, 19(9): 962-964.
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005-2009[J]. Epilepsia, 2010, 51(4):676-685.
Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy[J]. Neurology, 2001, 57(3):445-449.
Zhang Y, Zheng YX, Zhu JM, et al. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children:a meta-analysis[J]. J Zhejiang Univ Sci B, 2015, 16(7):611-621.
Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years[J]. Clin Pediatr (Phila), 1999, 38(2):93-98.
